The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II
- 18 August 2006
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 49 (10) , 2337-2340
- https://doi.org/10.1007/s00125-006-0387-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Variation in the UCP2-UCP3 Gene Cluster Predicts the Development of Type 2 Diabetes in Healthy Middle-Aged MenDiabetes, 2006
- Give me A5 for lipoprotein hydrolysis!Journal of Clinical Investigation, 2005
- A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentrationJournal of Lipid Research, 2005
- Determination of the Functionality of Common APOA5 PolymorphismsJournal of Biological Chemistry, 2005
- The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?Current Opinion in Lipidology, 2004
- APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart diseaseJournal of Lipid Research, 2004
- Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11Genomics, 2004
- Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.Human Molecular Genetics, 2002
- Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglyceridesHuman Molecular Genetics, 2002
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001